Nephrogenic diabetes insipidus

Annual Review of Physiology

Volumn 63, Issue , 2001, Pages 607-630

  Morello, J P ^a   Bichet, D G ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

AQP2 mutations; AVPR2 mutations; Countercurrent system; Misfolded V2 receptors; Pharmacological chaperones

Indexed keywords

AQUAPORIN 2; CHAPERONE; LIXIVAPTAN; N TERT BUTYL 4 [5' ETHOXY 4 (2 MORPHOLINOETHOXY) 2' OXOSPIRO[CYCLOHEXANE 1,3' INDOLE] 1' SULFONYL] 3 METHOXYBENZAMIDE; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

CELL MEMBRANE; CLINICAL FEATURE; DRUG MECHANISM; GENE MUTATION; HUMAN; KIDNEY CONCENTRATING CAPACITY; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; REVIEW; X CHROMOSOME LINKED DISORDER;

AMINO ACID SEQUENCE; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, VASOPRESSIN;

EID: 0035052523     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.63.1.607     Document Type: Review

References (142)

1. Endocrinology: Survival as a discipline in the 21st century?
2. 2O balance
3. Polyuria - A pathophysiological approach
4. Disorders of urinary concentration and dilution
5. Sequestration of urea and nonurea solutes in renal tissues of rats with hereditary hypothalamic diabetes insipidus: Effect of vasopressin and dehydration on the countercurrent mechanism
6. Aquaporin CHIP: The archetypal molecular water channel
7. The aquaporin family of water channel proteins in clinical medicine
8. CHIP28 water channels are localized in constitutively water-permeable segments of the nephron
9. Urea transporters in kidney: Molecular analysis and contribution to the urinary concentrating process
10. Posterior pituitary and water metabolism
11. Molecular cloning of a chloride channel that is regulated by dehydration and expressed predominantly in kidney medulla
12. Localization and functional characterization of rat kidney-specific chloride channel ClC-K1
13. Kidney kinetics and chloride ion pumps
14. Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel
15. Roles of Na-K-2Cl and Na-Cl cotransporters and ROMK potassium channels in urinary concentrating mechanism
16. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2
17. + channel, ROMK
18. Mutations in the gene encoding the inwardly rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: Evidence for genetic heterogeneity
19. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III
20. ADH action: Evidence for a membrane shuttle mechanism
21. Molecular physiology of urinary concentrating mechanism: Regulation of aquaporin water channels by vasopressin
22. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel
23. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells
24. A heterotrimeric G protein of the Gi family is required for cAMP-triggered trafficking of aquaporin 2 in kidney epithelial cells
25. Expression of syntaxins in rat kidney
26. Rat kidney papilla contains abundant synaptobrevin protein that participates in the fusion of antidiuretic hormone-regulated water channel-containing endosomes in vitro
27. Identification of Rab3-,Rab5a- and synaptobrevin II-like proteins in a preparation of rat kidney vesicles containing the vasopressin-regulated water channel
28. Expression of VAMP-2-like protein in kidney collecting duct intracellular vesicles: Colocalization with aquaporin-2 water channels
29. Calcium and cyclic adenosine monophosphate as second messengers for vasopressin in the rat inner medullary collecting duct
30. cAMP-dependent protein kinase mediates hydrosmotic effect of vasopressin in collecting duct
31. Cellular mechanisms of aquaporin trafficking
32. Vasopressin: Possible role of microtubules and microfilaments in its action
33. The AQP2 water channel: Effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats
34. Molecular cloning and characterization of the vasopressin-regulated urea transporter of rat kidney collecting ducts
35. Modulation of vasopressin-elicited water transport by trafficking of aquaporin 2-containing vesicles
36. Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2
37. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct
38. Generation and pheno-type of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4
39. Severely impaired urinary concentrating ability in transgenic mice lacking aquaporin-1 water channels
40. Reduced water permeability and altered ultrastructure in thin descending limb of Henle in aquaporin-1 null mice
41. Nephrogenic diabetes insipidus in mice lacking aquaporin-3 water channels
42. Uncompensated polyuria in a mouse model of Bartter's syndrome
43. V2 vasopressin receptor function studied in mice and yeast
44. Defective proximal tubular fluid reabsorption in transgenic aquaporin-1 null mice
45. Tetrameric assembly of CHIP28 water channels in liposomes and cell membranes: A freeze-fracture study
46. Fourfold reduction of water permeability in inner medullary collecting duct of aquaporin-4 knockout mice
47. Mutations in aquaporin-1 in phenotypically normal humans without functional CHIP water channels
48. Linkage between the Colton blood group locus and ASSP11 on chromosome 7
49. Human red cell aquaporin CHIP. I. Molecular characterization of ABH and Colton blood group antigens
50. Molecular cloning of the receptor for human antidiuretic hormone
51. Structure and chromosomal localization of the human antidiuretic hormone receptor gene
52. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus
53. Nephrogenic diabetes insipidus in North America: The Hopewell hypothesis
54. X-linked nephrogenic diabetes insipidus: From the ship Hopewell to restriction fragment length polymorphism studies
55. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis
56. A null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred
57. Nephrogenic diabetes insipidus
58. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus
59. Molecular analysis of X-linked nephrogenic diabetes insipidus
60. On the mode of hereditary transmission in diabetes insipidus
61. Congenital defect of water metabolism
62. Nephrogenic diabetes insipidus transmitted by females and appearing during infancy in males
63. Disorders of the posterior pituitary in children
64. Nephrogenic diabetes insipidus: Clinical and pathophysiological aspects
65. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation
66. Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation
67. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: Molecular basis of a mild clinical phenotype
68. The LDL receptor locus in familial hypercholesterolemia: Mutational analysis of a membrane protein
69. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide
70. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer
71. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: Analysis of expression, processing, and function
72. Binding, intracellular transport, and biosynthesisdefective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus
73. Functional characterization of five V2 vasopressin receptor gene mutations
74. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones
75. Folding of secretory and membrane proteins
76. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells
77. Defective processing and expression of thiazidesensitive Na-Cl cotransporter as a cause of Gitelman's syndrome
78. An intracellular trafficking defect in type I cystinuria rBAT mutants M467T and M467K
79. Protein misfolding and degradation in genetic diseases
80. Conformational disease
81. Inherited disorders of the renal tubule
82. Structural implication for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors
83. Nonpeptide antagonists for vasopressin receptors: Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist
84. VPA-985 a nonpeptide orally active and selective vasopressin V2 receptor antagonist
85. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist
86. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs
87. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein
88. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation
89. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR
90. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency
91. Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators
92. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
93. Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor
94. Thermodynamic and kinetic examination of protein stabilization by glycerol
95. Efficient in vitro folding of the three disulfide derivatives of hen lysozyme in the presence of glycerol
96. Microtubule assembly in the absence of added nucleotides
97. Commentary: Antagonists to the rescue
98. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine
99. Assignment of the human gene for the water channel of renal collecting duct aquaporin 2 (AQP2) to chromosome 12 region q12→q13
100. Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct
101. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing
102. New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels
103. Misfolding of mutant aquaporin-2 water channels in nephrogenic diabetes insipidus
104. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus
105. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex
106. An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus
107. Nephrogenic diabetes insipidus
108. Recommendations for a nomenclature system for human gene mutations
109. The binding site of neuropeptide vasopressin V1a receptor: Evidence for a major localization within transmembrane regions
110. Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus
111. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus
112. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus
113. Brief report: A molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus
114. Brief report: A mutation in the vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus
115. Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus
116. Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus
117. Nephrogenic diabetes insipidus: An X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal
118. Mutations in the vasopressin V2 receptor gene in two families with nephrogenic diabetes insipidus
119. Inheritance of mutations in the V2 receptor gene in thirteen families with nephrogenic diabetes insipidus
120. Two novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus
121. The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin
122. Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus
123. Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus
124. Novel mutations in the V2 vasopressin receptor gene in two pedigrees with congenital nephrogenic diabetes insipidus
125. Expression studies of two vasopressin V2 receptor gene mutations R202C and 804insG, in nephrogenic diabetes insipidus
126. Analysis of vasopressin receptor type II (V2R) gene in three Japanese pedigrees with congenital nephrogenic diabetes insipidus: Identification of a family with complete deletion of the V2R gene
127. Two novel mutations in the aquaporin-2 and the vasopressin V2 receptor genes in patients with congenital nephrogenic diabetes insipidus
128. Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus
129. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus
130. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus
131. Biochemical basis of partial NDI phenotypes
132. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus
133. Nephrogen diabetes insipidusos betegek molekularis biologia vizsgalata
134. V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms
135. Mutational analyses of AVPR2 gene in three Japanese families with X-linked nephrogenic diabetes insipidus: Two recurrent mutations R137H and delta V278, caused by the hypermutability at CpG dinucleotides
136. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus
137. Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene
138. Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response
139. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation
140. Novel mutations in aquaporin-2 gene in female siblings with nephrogenic diabetes insipidus: Evidence of disrupted water channel function
141. Aquaporin-2, a vasopressin-sensitive water channel, and nephrogenic diabetes insipidus
142. Threedimensional organization of a human water channel